Appoints Eric Davidson as Chief Commercial Officer Mendaera Inc., a healthcare technology company focused on developing an innovative handheld robotic platform for interventional procedures, appoints Eric Davidson as its first Chief Commercial Officer (CCO). In this newly created role, Davidson…
Cyrus Selects CYR212 as Candidate for IgG-Driven Autoimmune Diseases Cyrus Biotechnology, an AI-driven therapeutics company, announced the selection of CYR212 as its clinical development candidate for chronic IgG-driven autoimmune diseases. CYR212 is a next-generation, engineered Immunoglobulin-G (IgG) protease designed to…
Peanut Allergy Treatment Palforzia® Indication Expanded by European Commission for Toddlers Stallergenes Greer, a biopharmaceutical company specializing in allergen immunotherapy (AIT), has announced that the European Commission (EC) has granted approval for the extension of Palforzia® (defatted powder of Arachis…
Cardiometabolic Innovator Verdiva Bio Launches with $410M+ Series A to Advance Therapies Verdiva Bio Limited (“Verdiva”), a new clinical-stage biopharmaceutical company, announced its official launch today, aiming to innovate therapies for obesity and other cardiometabolic disorders. The company has raised…
Ambry Genetics Data Enhances BRCA2 Variant Classification for Hereditary Cancers Ambry Genetics, a leader in clinical genomic testing, has announced its contribution to a groundbreaking study published in Nature, which significantly enhances the understanding of BRCA2 gene variants. As genetic…
MaaT Pharma Announces Positive Phase 3 ARES Results for MaaT013 in Acute GvHD MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotechnology company specializing in Microbiome Ecosystem Therapies™ (MET) to improve survival for cancer patients through immune modulation, has announced positive topline…
Cofactor Genomics Announces CEO Change for Growth and OncoPrism Expansion Cofactor Genomics, Inc., a leader in precision medicine through RNA decoding, has appointed Chris Parker as CEO and Board Member to drive the company’s efforts in advancing immunotherapy. At the…
VitVio Enhances Orthopaedic Hospital OR Efficiency and Safety with AI Platform The Royal Orthopaedic Hospital (ROH), one of the UK’s leading institutions in orthopaedic care, has launched a pilot program with VitVio, a company at the forefront of integrating artificial…
Vir Biotechnology Reports Positive Data in Ongoing Trials for VIR-5818 and VIR-5500 Vir Biotechnology, Inc. (Nasdaq: VIR) has presented encouraging preliminary Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets HER2-expressing solid tumors, and VIR-5500,…
Nalu PNS System Cuts Healthcare Costs for Chronic Pain Patients Nalu Medical, Inc., a prominent leader in peripheral nerve stimulation (PNS), recently announced the publication of a study in Pain Management journal that demonstrates the significant healthcare cost savings associated…
GeneDx Advances Genomics Research, Impacting Over 22,000 Patients GeneDx (Nasdaq: WGS), a pioneer in genomic insights for improved health outcomes, continues to make significant strides in advancing scientific research, especially in the area of gene-disease relationships. In 2024 alone, the…
Diabetes Insulin Dosing Enhanced Through Hedia and Glooko Partnership Glooko, Inc. and Hedia have launched an innovative interoperable solution designed to improve diabetes management. The solution integrates connected care, remote patient monitoring, and digital therapeutic technologies to provide enhanced support…